1. Home
  2. PRTC vs FLOC Comparison

PRTC vs FLOC Comparison

Compare PRTC & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • FLOC
  • Stock Information
  • Founded
  • PRTC 2015
  • FLOC 1996
  • Country
  • PRTC United States
  • FLOC United States
  • Employees
  • PRTC N/A
  • FLOC N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • FLOC Metal Fabrications
  • Sector
  • PRTC Health Care
  • FLOC Industrials
  • Exchange
  • PRTC Nasdaq
  • FLOC Nasdaq
  • Market Cap
  • PRTC 388.6M
  • FLOC 417.7M
  • IPO Year
  • PRTC N/A
  • FLOC 2025
  • Fundamental
  • Price
  • PRTC $15.39
  • FLOC $16.41
  • Analyst Decision
  • PRTC Buy
  • FLOC Strong Buy
  • Analyst Count
  • PRTC 1
  • FLOC 6
  • Target Price
  • PRTC $45.00
  • FLOC $30.17
  • AVG Volume (30 Days)
  • PRTC 5.0K
  • FLOC 327.3K
  • Earning Date
  • PRTC 08-28-2025
  • FLOC 11-06-2025
  • Dividend Yield
  • PRTC N/A
  • FLOC 1.95%
  • EPS Growth
  • PRTC N/A
  • FLOC N/A
  • EPS
  • PRTC 0.20
  • FLOC 3.01
  • Revenue
  • PRTC $6,391,000.00
  • FLOC $760,923,000.00
  • Revenue This Year
  • PRTC N/A
  • FLOC $47.57
  • Revenue Next Year
  • PRTC N/A
  • FLOC $8.16
  • P/E Ratio
  • PRTC $7.29
  • FLOC $5.46
  • Revenue Growth
  • PRTC 1265.60
  • FLOC 155.05
  • 52 Week Low
  • PRTC $13.30
  • FLOC $14.89
  • 52 Week High
  • PRTC $24.99
  • FLOC $30.50
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 34.46
  • FLOC 51.62
  • Support Level
  • PRTC $15.75
  • FLOC $15.00
  • Resistance Level
  • PRTC $16.75
  • FLOC $16.28
  • Average True Range (ATR)
  • PRTC 0.62
  • FLOC 0.54
  • MACD
  • PRTC -0.14
  • FLOC 0.11
  • Stochastic Oscillator
  • PRTC 0.00
  • FLOC 88.02

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About FLOC Flowco Holdings Inc. Class A Common Stock

Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.

Share on Social Networks: